Generation of Kidney Cancer-Specific Antitumor Immune Responses Using Peripheral Blood Monocytes Transduced with a Recombinant Adenovirus Encoding Carbonic Anhydrase 9

Clinical Cancer Research

Volumn 10, Issue 4, 2004, Pages 1421-1429

  Mukouyama, Hideki ^a   Janzen, Nicolette K ^a   Hernandez, Jose M ^a   Lam, John S ^a   Caliliw, Randy ^a   Wang, Allen Y ^a   Figlin, Robert A ^a   Belldegrun, Arie S ^a   Zeng, Gang ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE IX; UNCLASSIFIED DRUG;

ARTICLE; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; MONOCYTE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; TUMOR IMMUNITY; VIRUS RECOMBINANT;

ADENOVIRIDAE; BLOTTING, WESTERN; CANCER VACCINES; CARBONIC ANHYDRASES; CARCINOMA, RENAL CELL; CELL ADHESION; CELL LINE, TUMOR; CLONING, MOLECULAR; CYTOKINES; FLOW CYTOMETRY; GENETIC VECTORS; HUMANS; IMMUNOTHERAPY; KIDNEY NEOPLASMS; LEUKOCYTES, MONONUCLEAR; MICROSCOPY, PHASE-CONTRAST; MONOCYTES; PHENOTYPE; T-LYMPHOCYTES;

EID: 1642368175     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-03-0067     Document Type: Article

References (30)

1. Figlin, R. A. Renal cell carcinoma: management of advanced disease. J. Urol., 161: 381-387, 1999.
2. Hanninen, E. L., Korfer, A., Hadam, M., Schneekloth, C., Dallmann, I., Menzel, T., Kirchner, H., Poliwoda, H., and Atzpodien, J. Biological monitoring of low-dose interleukin 2 in humans: soluble interleukin 2 receptors, cytokines, and cell surface phenotypes. Cancer Res., 51: 6312-6316, 1991.
3. Rosenberg, S. A. Progress in human tumour immunology and immunotherapy. Nature, 411: 380-384, 2001.
4. Li, G., Passebose-Faure, K., Lambert, C., Gentil-Perret, A., Blanc, F., Oosterwijk, E., Mosnier, J. F., Genin, C., and Tostain, J. Flow cytometric analysis of antigen expression in malignant and normal renal cells. Anticancer Res., 20: 2773-2778, 2000.
5. Neumann, E., Engelsberg, A., Decker, J., Strorkel, S., Jaeger, E., Huber, C., and Seliger, B. Heterogeneous expression of the tumor-associated antigens RAGE-1, PRAME, and glycoprotein 75 in human renal cell carcinoma: candidates for T-cell-based immunotherapies? Cancer Res., 58: 4090-4095, 1998.
6. Hanada, K., Perry-Lalley, D. M., Ohnmacht, G. A., Bettinotti, M. P., and Yang, J. C. Identification of fibroblast growth factor-5 as an overexpressed antigen in multiple human adenocarcinomas. Cancer Res., 61: 5511-5516, 2001.
7. Pastorekova, S., Zavadova, Z., Kostal, M., Babusikova, O., and Zavada, J. A novel quasi-viral agent, MaTu, is a two-component system. Virology, 187: 620-626, 1992.
8. Ivanova, A. V., Ivanov, S. V., Danilkovitch-Miagkova, A., and Lerman, M. I. Regulation of STRA13 by the von Hippel-Lindau tumor suppressor protein, hypoxia, and the UBC9/Ubiquitin proteasome degradation pathway. J. Biol. Chem., 276: 15306-15315, 2001.
9. Grabmaier, K., Vissers, J. L., De Weijert, M. C., Oosterwijk-Wakka, J. C., Van Bokhoven, A., Brakenhoff, R. H., Noessner, E., Mulders, P. A., Merkx, G., Figdor, C. G., Adema, G. J., and Oosterwijk, E. Molecular cloning and immunogenicity of renal cell carcinoma-associate antigen G250. Int. J. Cancer, 85: 865-870, 2000.
10. Vissers, J. L. M., De Vires, I. J. M., Schreurs, M. W. J., Engelen, L. P. H., Oosterwijk, E., Figdor, C. G., and Adema, G. J. The renal cell carcinoma-associated antigen G250 encodes a human leukocyte antigen (HLA)-A2.1-restricted epitope recognized by cytotoxic T lymphocytes. Cancer Res., 59: 5554-5559, 1999.
11. + T lymphocytes. Int. J. Cancer, 100: 441-444, 2002.
12. Bui, M. H., Zisman, A., Pantuck, A. J., Han, K. R., Wieder, J., and Belldegrun, A. S. Prognostic factors and molecular markers for renal cell carcinoma. Expert Rev. Anticancer Ther., 1: 565-575, 2001.
13. Butterfield, L. H., Jilani, S. M., Chakraborty, N. G., Bui, L. A., Ribas, A., Dissette, V. B., Lau, R., Gamradt, S. C., Glaspy, J. A., McBride, W. H., Mukherji, B., and Economou, J. S. Generation of melanoma-specific cytotoxic T lymphocytes by dendritic cells transduced with a MART-1 adenovirus. J. Immunol., 161: 5607-5613, 1998.
14. Linette, G. P., Shankara, S., Longerich, S., Yang, S., Doll, R., Nicolette, C., Preffer, F. I., Roberts, B. L., and Haluska, F. G. In vitro priming with adenovirus/gp100 antigen-transduced dendritic cells reveals the epitope specificity of HLA-A*0201-restricted CD8+ T cells in patients with melanoma. J. Immunol., 164: 3402-3412, 2000.
15. Liu, Y., Chiriva-Internati, M., Grizzi, F., Salati, E., Roman, J. J., Lim, S., and Hermonat, P. L. Rapid induction of cytotoxic T-cell response against cervical cancer cells human papillomavirus type 16 E6 antigen gene delivery into human dendritic cells by an adeno-associated virus vector. Cancer Gene Ther., 8: 948-957, 2001.
16. Ponnazhagan, S., Mahendra, G., Curiel, D. T., and Shaw, D. R. Adeno-associated virus type 2-mediated transduction of human monocyte derived dendritic cells: implications for ex vivo immunotherapy. J. Virol., 75: 9493-9501, 2001.
17. Zhang, Y., Chirmule, N., Gao, G., and Wilson, J. CD40 ligand-dependent activation of cytotoxic T lymphocytes by adeno-associated virus vectors in vivo: role of immature dendritic cells. J. Virol., 74: 8003-8010, 2000.
18. Butterfield, L. H., Ribas, A., Dissette, V. B., Amarnani, S. N., Vu, H. T., Oseguera, D., Wang, H. J., Elashoff, R. M., McBride, W. H., Mukherji, B., Cochran, A. J., Glaspy, J. A., and Economou, J. S. Determinant spreading associated with clinical response in dendritic cell-based immunotherapy for malignant melanoma. Clin. Cancer Res., 9: 998-1008, 2003.
19. Smith, J. W., 2nd, Walker, E. B., Fox, B. A., Haley, D., Wisner, K. P., Doran, T., Fisher, B., Justice, L., Wood, W., Vetto, J., Maecker, H., Dols, A., Meijer, S., Hu, H. M., Romero, P., Alvord, W. G., and Urba, W. J. Adjuvant immunization of HLA-A2-positive melanoma patients with a modified gp100 peptide induces peptide-specific CD8+ T-cell responses. J. Clin. Oncol., 21: 1562-1573, 2003.
20. Hernandez, J. M., Bui, M., Han, K. R., Mukouyama, H., Freitas, D., Nguyen, D., Caliliw, R., Shintaku, P. I., Paik, S., Tso, C. L., Figlin, R., and Belldegrun, A. S. Novel kidney cancer immunotherapy based on the granulocyte-macrophage colony-stimulating factor and carbonic anhydrase IX fusion gene. Clin. Cancer Res., 9: 1906-1916, 2003.
21. He, T. C., Zhou, S., daCosta, L. T. Yu, J., Kinzler, K. W., and Vogelstein, B. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA, 95: 2509-2514, 1998.
22. Hanahan, D. Studies on transformation of Escherichia coli with plasmid. J. Mol. Biol., 166: 557-580, 1983.
23. Mann, H. B., and Whitney, R. D. On a test of whether one of two random variables is stochastically larger than the other. Ann. Math. Stat., 18: 52-54, 1947.
24. Zeng, G., Li, Y., El-Gamil, M., Sidney, J., Sette, A., Wang, R. F., Rosenberg, S. A., and Robbins, P. F. Generation of NY-ESO-1-specific CD4+ and CD8+ T cells by a single peptide with duel MHC class 1 and class II specificities: a new strategy for vaccine design. Cancer Res., 62: 3630-3635, 2002.
25. Tuettenberg, A., Jonuleit, H., Tuting, T., Bruck, J., Knop, J., and Enk, A. H. Priming of T cells with Ad-transduced DC followed by expansion with peptide-pulsed DC significantly enhances the induction of tumor-specific CD8+ T cells: implications for an efficient vaccination strategy. Gene Ther., 10: 243-250, 2003.
26. Hengel, H., and Koszinowski, U. H. Interference with antigen processing by viruses. Curr. Opin. Immunol., 9: 470-476, 1997.
27. Storkus, W. J., and Dawson, J. R. Target structures involved in natural killing (NK): characteristics, distribution, and candidate molecules. Crit. Rev. Immunol., 10: 393-416, 1991.
28. Burgert, H. G., Ruzsics, Z., Obermeier, S., Hilgendorf, A., Windheim, M., and Elsing, A. Subversion of host defense mechanisms by adenoviruses. Curr. Top Microbiol. Immunol., 269: 273-318, 2002.
29. Robertson, M. J., Cameron, C., Lazo, S., Cochran, K. J., Voss, S. D., and Ritz, J. Costimulation of human natural killer cell proliferation: role of accessory cytokines and cell contact-dependent signals. Nat. Immun., 15: 213-226, 1996-97.
30. Lewis, C. E., Ramshaw, A. L., Lorenzen, J., and McGee, J. O. Basic fibroblast growth factor and interleukins 4 and 6 stimulate the release of IFN-γ by individual NK cells. Cell Immunol., 132: 158-167, 1991.